Surgery remains an important treatment modality in the multidisciplinary management of patients with Crohn’s disease (CD). To illustrate the recent advances in the management of postoperative CD we outline the contemporary approach to treatment: diagnosing disease recurrence using endoscopy or noninvasive methods and risk stratification underlying decisions to institute treatment. Endoscopic scoring indices are being refined to guide treatment decisions by accurately estimating the risk of recurrence based on endoscopic appearance. The original Rutgeerts score has been modified to separate anastomotic lesions from lesions in the neoterminal ileum. Two further indices, the REMIND score and the POCER index, were recently developed with the same intention. Noninvasive monitoring for recurrence using a method with high negative predictive value has the potential to simplify management algorithms and only perform ileocolonoscopy in a subset of patients. Fecal calprotectin, intestinal ultrasound, and magnetic resonance enterography are all being evaluated for this purpose. The use of infliximab for the prevention of postoperative recurrence is well supported by data, but management decisions are fraught with uncertainty for patients with previous exposure to biologics. Data on the use of ustekinumab and vedolizumab for postoperative CD are emerging, but controlled studies are lacking.
JCM, Free Full-Text, man blue skin
JCM, Free Full-Text, nelson games sbo
JCM Construction, LLC
A real-time dynamic 3D model of the human inguinal region for
JCM, Free Full-Text, nelson games sbo
FREE T Access Control > RF + Free hands
JCM, Free Full-Text, rubinstein taybi genereviews
JCM Free Full-Text Pathophysiology And Clinical Management, 56% OFF
JCM, Free Full-Text, man blue skin
JCM, Free Full-Text
Journal of Clinical Medicine An Open Access Journal from MDPI
JCM, Free Full-Text